aluates Reports

$ 0.0

Automative

Antibody-drug Conjugates - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Published Date: March 2024

Report Code: QYRE-Auto-31N9042

Global Antibody drug Conjugates Market Insights and Forecast to 2028

BUY CHAPTERS

Antibody-drug Conjugates - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-31N9042

Report

March 2024

Pages:87

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Antibody-drug Conjugates - Market Size

The global market for Antibody-drug Conjugates was estimated to be worth US$ 2831.3 million in 2023 and is forecast to a readjusted size of US$ 3919.8 million by 2030 with a CAGR of 4.7% during the forecast period 2024-2030

Antibody-drug Conjugates - Market

Antibody Drug Conjugates (ADCs) are monoclonal antibodies (mAbs) attached to biologically active drugs by chemical linkers with labile bonds. By combining the unique targeting of mAbs with the cancer-killing ability of cytotoxic drugs, ADCs allow sensitive discrimination between healthy and diseased tissue.

North America is the largest market with about 59% market share. Europe is follower, accounting for about 27% market share.

The key players are ImmunoGen, Seattle Genetics, Roche, Takeda etc. Takeda is the largest manufacturer with about 57% revenue market share.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Antibody-drug Conjugates, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Antibody-drug Conjugates by region & country, by Type, and by Application.

The Antibody-drug Conjugates market size, estimations, and forecasts are provided in terms of sales volume (Kg) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antibody-drug Conjugates.

Market Segmentation

Scope of Antibody-drug Conjugates - Market Report

Report Metric	Details
Report Name	Antibody-drug Conjugates - Market
Forecasted market size in 2030	US$ 3919.8 million
CAGR	4.7%
Forecasted years	2024 - 2030
Segment by Type:	Adcetris Kadcyla
Segment by Application	Breast Cancer Lymphoma
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	ImmunoGen, Seattle Genetics, Roche, Takeda
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Antibody-drug Conjugates manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Antibody-drug Conjugates in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Antibody-drug Conjugates in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

FAQ for this report

What is the Antibody-drug Conjugates - Market size in 2030?

Ans: The Antibody-drug Conjugates - Market size in 2030 will be US$ 3919.8 million.

What is the Antibody-drug Conjugates - Market share by region?

Ans: Europe is follower, accounting for about 27% market share.

What is the Takeda share in Antibody-drug Conjugates - Market?

Ans: Takeda is the largest manufacturer with about 57% revenue market share.

Who are the main players in the Antibody-drug Conjugates - Market report?

Ans: The main players in the Antibody-drug Conjugates - Market are ImmunoGen, Seattle Genetics, Roche, Takeda

What are the Application segmentation covered in the Antibody-drug Conjugates - Market report?

Ans: The Applications covered in the Antibody-drug Conjugates - Market report are Breast Cancer, Lymphoma

What are the Type segmentation covered in the Antibody-drug Conjugates - Market report?

Ans: The Types covered in the Antibody-drug Conjugates - Market report are Adcetris, Kadcyla

1 Market Overview

1.1 Antibody-drug Conjugates Product Introduction

1.2 Global Antibody-drug Conjugates Market Size Forecast

1.2.1 Global Antibody-drug Conjugates Sales Value (2019-2030)

1.2.2 Global Antibody-drug Conjugates Sales Volume (2019-2030)

1.2.3 Global Antibody-drug Conjugates Sales Price (2019-2030)

1.3 Antibody-drug Conjugates Market Trends & Drivers

1.3.1 Antibody-drug Conjugates Industry Trends

1.3.2 Antibody-drug Conjugates Market Drivers & Opportunity

1.3.3 Antibody-drug Conjugates Market Challenges

1.3.4 Antibody-drug Conjugates Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Antibody-drug Conjugates Players Revenue Ranking (2023)

2.2 Global Antibody-drug Conjugates Revenue by Company (2019-2024)

2.3 Global Antibody-drug Conjugates Players Sales Volume Ranking (2023)

2.4 Global Antibody-drug Conjugates Sales Volume by Company Players (2019-2024)

2.5 Global Antibody-drug Conjugates Average Price by Company (2019-2024)

2.6 Key Manufacturers Antibody-drug Conjugates Manufacturing Base Distribution and Headquarters

2.7 Key Manufacturers Antibody-drug Conjugates Product Offered

2.8 Key Manufacturers Time to Begin Mass Production of Antibody-drug Conjugates

2.9 Antibody-drug Conjugates Market Competitive Analysis

2.9.1 Antibody-drug Conjugates Market Concentration Rate (2019-2024)

2.9.2 Global 5 and 10 Largest Manufacturers by Antibody-drug Conjugates Revenue in 2023

2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antibody-drug Conjugates as of 2023)

2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 Adcetris

3.1.2 Kadcyla

3.2 Global Antibody-drug Conjugates Sales Value by Type

3.2.1 Global Antibody-drug Conjugates Sales Value by Type (2019 VS 2023 VS 2030)

3.2.2 Global Antibody-drug Conjugates Sales Value, by Type (2019-2030)

3.2.3 Global Antibody-drug Conjugates Sales Value, by Type (%) (2019-2030)

3.3 Global Antibody-drug Conjugates Sales Volume by Type

3.3.1 Global Antibody-drug Conjugates Sales Volume by Type (2019 VS 2023 VS 2030)

3.3.2 Global Antibody-drug Conjugates Sales Volume, by Type (2019-2030)

3.3.3 Global Antibody-drug Conjugates Sales Volume, by Type (%) (2019-2030)

3.4 Global Antibody-drug Conjugates Average Price by Type (2019-2030)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Breast Cancer

4.1.2 Lymphoma

4.2 Global Antibody-drug Conjugates Sales Value by Application

4.2.1 Global Antibody-drug Conjugates Sales Value by Application (2019 VS 2023 VS 2030)

4.2.2 Global Antibody-drug Conjugates Sales Value, by Application (2019-2030)

4.2.3 Global Antibody-drug Conjugates Sales Value, by Application (%) (2019-2030)

4.3 Global Antibody-drug Conjugates Sales Volume by Application

4.3.1 Global Antibody-drug Conjugates Sales Volume by Application (2019 VS 2023 VS 2030)

4.3.2 Global Antibody-drug Conjugates Sales Volume, by Application (2019-2030)

4.3.3 Global Antibody-drug Conjugates Sales Volume, by Application (%) (2019-2030)

4.4 Global Antibody-drug Conjugates Average Price by Application (2019-2030)

5 Segmentation by Region

5.1 Global Antibody-drug Conjugates Sales Value by Region

5.1.1 Global Antibody-drug Conjugates Sales Value by Region: 2019 VS 2023 VS 2030

5.1.2 Global Antibody-drug Conjugates Sales Value by Region (2019-2024)

5.1.3 Global Antibody-drug Conjugates Sales Value by Region (2025-2030)

5.1.4 Global Antibody-drug Conjugates Sales Value by Region (%), (2019-2030)

5.2 Global Antibody-drug Conjugates Sales Volume by Region

5.2.1 Global Antibody-drug Conjugates Sales Volume by Region: 2019 VS 2023 VS 2030

5.2.2 Global Antibody-drug Conjugates Sales Volume by Region (2019-2024)

5.2.3 Global Antibody-drug Conjugates Sales Volume by Region (2025-2030)

5.2.4 Global Antibody-drug Conjugates Sales Volume by Region (%), (2019-2030)

5.3 Global Antibody-drug Conjugates Average Price by Region (2019-2030)

5.4 North America

5.4.1 North America Antibody-drug Conjugates Sales Value, 2019-2030

5.4.2 North America Antibody-drug Conjugates Sales Value by Country (%), 2023 VS 2030

5.5 Europe

5.5.1 Europe Antibody-drug Conjugates Sales Value, 2019-2030

5.5.2 Europe Antibody-drug Conjugates Sales Value by Country (%), 2023 VS 2030

5.6 Asia Pacific

5.6.1 Asia Pacific Antibody-drug Conjugates Sales Value, 2019-2030

5.6.2 Asia Pacific Antibody-drug Conjugates Sales Value by Country (%), 2023 VS 2030

5.7 South America

5.7.1 South America Antibody-drug Conjugates Sales Value, 2019-2030

5.7.2 South America Antibody-drug Conjugates Sales Value by Country (%), 2023 VS 2030

5.8 Middle East & Africa

5.8.1 Middle East & Africa Antibody-drug Conjugates Sales Value, 2019-2030

5.8.2 Middle East & Africa Antibody-drug Conjugates Sales Value by Country (%), 2023 VS 2030

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Antibody-drug Conjugates Sales Value Growth Trends, 2019 VS 2023 VS 2030

6.2 Key Countries/Regions Antibody-drug Conjugates Sales Value

6.2.1 Key Countries/Regions Antibody-drug Conjugates Sales Value, 2019-2030

6.2.2 Key Countries/Regions Antibody-drug Conjugates Sales Volume, 2019-2030

6.3 United States

6.3.1 United States Antibody-drug Conjugates Sales Value, 2019-2030

6.3.2 United States Antibody-drug Conjugates Sales Value by Type (%), 2023 VS 2030

6.3.3 United States Antibody-drug Conjugates Sales Value by Application, 2023 VS 2030

6.4 Europe

6.4.1 Europe Antibody-drug Conjugates Sales Value, 2019-2030

6.4.2 Europe Antibody-drug Conjugates Sales Value by Type (%), 2023 VS 2030

6.4.3 Europe Antibody-drug Conjugates Sales Value by Application, 2023 VS 2030

6.5 China

6.5.1 China Antibody-drug Conjugates Sales Value, 2019-2030

6.5.2 China Antibody-drug Conjugates Sales Value by Type (%), 2023 VS 2030

6.5.3 China Antibody-drug Conjugates Sales Value by Application, 2023 VS 2030

6.6 Japan

6.6.1 Japan Antibody-drug Conjugates Sales Value, 2019-2030

6.6.2 Japan Antibody-drug Conjugates Sales Value by Type (%), 2023 VS 2030

6.6.3 Japan Antibody-drug Conjugates Sales Value by Application, 2023 VS 2030

6.7 South Korea

6.7.1 South Korea Antibody-drug Conjugates Sales Value, 2019-2030

6.7.2 South Korea Antibody-drug Conjugates Sales Value by Type (%), 2023 VS 2030

6.7.3 South Korea Antibody-drug Conjugates Sales Value by Application, 2023 VS 2030

6.8 Southeast Asia

6.8.1 Southeast Asia Antibody-drug Conjugates Sales Value, 2019-2030

6.8.2 Southeast Asia Antibody-drug Conjugates Sales Value by Type (%), 2023 VS 2030

6.8.3 Southeast Asia Antibody-drug Conjugates Sales Value by Application, 2023 VS 2030

6.9 India

6.9.1 India Antibody-drug Conjugates Sales Value, 2019-2030

6.9.2 India Antibody-drug Conjugates Sales Value by Type (%), 2023 VS 2030

6.9.3 India Antibody-drug Conjugates Sales Value by Application, 2023 VS 2030

7 Company Profiles

7.1 ImmunoGen

7.1.1 ImmunoGen Company Information

7.1.2 ImmunoGen Introduction and Business Overview

7.1.3 ImmunoGen Antibody-drug Conjugates Sales, Revenue and Gross Margin (2019-2024)

7.1.4 ImmunoGen Antibody-drug Conjugates Product Offerings

7.1.5 ImmunoGen Recent Development

7.2 Seattle Genetics

7.2.1 Seattle Genetics Company Information

7.2.2 Seattle Genetics Introduction and Business Overview

7.2.3 Seattle Genetics Antibody-drug Conjugates Sales, Revenue and Gross Margin (2019-2024)

7.2.4 Seattle Genetics Antibody-drug Conjugates Product Offerings

7.2.5 Seattle Genetics Recent Development

7.3 Roche

7.3.1 Roche Company Information

7.3.2 Roche Introduction and Business Overview

7.3.3 Roche Antibody-drug Conjugates Sales, Revenue and Gross Margin (2019-2024)

7.3.4 Roche Antibody-drug Conjugates Product Offerings

7.3.5 Roche Recent Development

7.4 Takeda

7.4.1 Takeda Company Information

7.4.2 Takeda Introduction and Business Overview

7.4.3 Takeda Antibody-drug Conjugates Sales, Revenue and Gross Margin (2019-2024)

7.4.4 Takeda Antibody-drug Conjugates Product Offerings

7.4.5 Takeda Recent Development

8 Industry Chain Analysis

8.1 Antibody-drug Conjugates Industrial Chain

8.2 Antibody-drug Conjugates Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Antibody-drug Conjugates Sales Model

8.5.2 Sales Channel

8.5.3 Antibody-drug Conjugates Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.2 Data Source

10.2 Author Details

10.3 Disclaimer

FEATURED COMPANIES

List of Tables

Table 1. Antibody-drug Conjugates Market Trends

Table 2. Antibody-drug Conjugates Market Drivers & Opportunity

Table 3. Antibody-drug Conjugates Market Challenges

Table 4. Antibody-drug Conjugates Market Restraints

Table 5. Global Antibody-drug Conjugates Revenue by Company (2019-2024) & (US$ Million)

Table 6. Global Antibody-drug Conjugates Revenue Market Share by Company (2019-2024)

Table 7. Global Antibody-drug Conjugates Sales Volume by Company (2019-2024) & (Kg)

Table 8. Global Antibody-drug Conjugates Sales Volume Market Share by Company (2019-2024)

Table 9. Global Market Antibody-drug Conjugates Price by Company (2019-2024) & (USD/Kg)

Table 10. Key Manufacturers Antibody-drug Conjugates Manufacturing Base Distribution and Headquarters

Table 11. Key Manufacturers Antibody-drug Conjugates Product Type

Table 12. Key Manufacturers Time to Begin Mass Production of Antibody-drug Conjugates

Table 13. Global Antibody-drug Conjugates Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antibody-drug Conjugates as of 2023)

Table 15. Mergers & Acquisitions, Expansion Plans

Table 16. Global Antibody-drug Conjugates Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)

Table 17. Global Antibody-drug Conjugates Sales Value by Type (2019-2024) & (US$ Million)

Table 18. Global Antibody-drug Conjugates Sales Value by Type (2025-2030) & (US$ Million)

Table 19. Global Antibody-drug Conjugates Sales Market Share in Value by Type (2019-2024) & (%)

Table 20. Global Antibody-drug Conjugates Sales Market Share in Value by Type (2025-2030) & (%)

Table 21. Global Antibody-drug Conjugates Sales Volume by Type: 2019 VS 2023 VS 2030 (Kg)

Table 22. Global Antibody-drug Conjugates Sales Volume by Type (2019-2024) & (Kg)

Table 23. Global Antibody-drug Conjugates Sales Volume by Type (2025-2030) & (Kg)

Table 24. Global Antibody-drug Conjugates Sales Market Share in Volume by Type (2019-2024) & (%)

Table 25. Global Antibody-drug Conjugates Sales Market Share in Volume by Type (2025-2030) & (%)

Table 26. Global Antibody-drug Conjugates Price by Type (2019-2024) & (USD/Kg)

Table 27. Global Antibody-drug Conjugates Price by Type (2025-2030) & (USD/Kg)

Table 28. Global Antibody-drug Conjugates Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)

Table 29. Global Antibody-drug Conjugates Sales Value by Application (2019-2024) & (US$ Million)

Table 30. Global Antibody-drug Conjugates Sales Value by Application (2025-2030) & (US$ Million)

Table 31. Global Antibody-drug Conjugates Sales Market Share in Value by Application (2019-2024) & (%)

Table 32. Global Antibody-drug Conjugates Sales Market Share in Value by Application (2025-2030) & (%)

Table 33. Global Antibody-drug Conjugates Sales Volume by Application: 2019 VS 2023 VS 2030 (Kg)

Table 34. Global Antibody-drug Conjugates Sales Volume by Application (2019-2024) & (Kg)

Table 35. Global Antibody-drug Conjugates Sales Volume by Application (2025-2030) & (Kg)

Table 36. Global Antibody-drug Conjugates Sales Market Share in Volume by Application (2019-2024) & (%)

Table 37. Global Antibody-drug Conjugates Sales Market Share in Volume by Application (2025-2030) & (%)

Table 38. Global Antibody-drug Conjugates Price by Application (2019-2024) & (USD/Kg)

Table 39. Global Antibody-drug Conjugates Price by Application (2025-2030) & (USD/Kg)

Table 40. Global Antibody-drug Conjugates Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Global Antibody-drug Conjugates Sales Value by Region (2019-2024) & (US$ Million)

Table 42. Global Antibody-drug Conjugates Sales Value by Region (2025-2030) & (US$ Million)

Table 43. Global Antibody-drug Conjugates Sales Value by Region (2019-2024) & (%)

Table 44. Global Antibody-drug Conjugates Sales Value by Region (2025-2030) & (%)

Table 45. Global Antibody-drug Conjugates Sales Volume by Region (Kg): 2019 VS 2023 VS 2030

Table 46. Global Antibody-drug Conjugates Sales Volume by Region (2019-2024) & (Kg)

Table 47. Global Antibody-drug Conjugates Sales Volume by Region (2025-2030) & (Kg)

Table 48. Global Antibody-drug Conjugates Sales Volume by Region (2019-2024) & (%)

Table 49. Global Antibody-drug Conjugates Sales Volume by Region (2025-2030) & (%)

Table 50. Global Antibody-drug Conjugates Average Price by Region (2019-2024) & (USD/Kg)

Table 51. Global Antibody-drug Conjugates Average Price by Region (2025-2030) & (USD/Kg)

Table 52. Key Countries/Regions Antibody-drug Conjugates Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030

Table 53. Key Countries/Regions Antibody-drug Conjugates Sales Value, (2019-2024) & (US$ Million)

Table 54. Key Countries/Regions Antibody-drug Conjugates Sales Value, (2025-2030) & (US$ Million)

Table 55. Key Countries/Regions Antibody-drug Conjugates Sales Volume, (2019-2024) & (Kg)

Table 56. Key Countries/Regions Antibody-drug Conjugates Sales Volume, (2025-2030) & (Kg)

Table 57. ImmunoGen Company Information

Table 58. ImmunoGen Introduction and Business Overview

Table 59. ImmunoGen Antibody-drug Conjugates Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)

Table 60. ImmunoGen Antibody-drug Conjugates Product Offerings

Table 61. ImmunoGen Recent Development

Table 62. Seattle Genetics Company Information

Table 63. Seattle Genetics Introduction and Business Overview

Table 64. Seattle Genetics Antibody-drug Conjugates Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)

Table 65. Seattle Genetics Antibody-drug Conjugates Product Offerings

Table 66. Seattle Genetics Recent Development

Table 67. Roche Company Information

Table 68. Roche Introduction and Business Overview

Table 69. Roche Antibody-drug Conjugates Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)

Table 70. Roche Antibody-drug Conjugates Product Offerings

Table 71. Roche Recent Development

Table 72. Takeda Company Information

Table 73. Takeda Introduction and Business Overview

Table 74. Takeda Antibody-drug Conjugates Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)

Table 75. Takeda Antibody-drug Conjugates Product Offerings

Table 76. Takeda Recent Development

Table 77. Key Raw Materials Lists

Table 78. Raw Materials Key Suppliers Lists

Table 79. Antibody-drug Conjugates Downstream Customers

Table 80. Antibody-drug Conjugates Distributors List

Table 81. Research Programs/Design for This Report

Table 82. Key Data Information from Secondary Sources

Table 83. Key Data Information from Primary Sources

List of Figures

Figure 1. Antibody-drug Conjugates Product Picture

Figure 2. Global Antibody-drug Conjugates Sales Value, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Antibody-drug Conjugates Sales Value (2019-2030) & (US$ Million)

Figure 4. Global Antibody-drug Conjugates Sales Volume (2019-2030) & (Kg)

Figure 5. Global Antibody-drug Conjugates Sales Price (2019-2030) & (USD/Kg)

Figure 6. Antibody-drug Conjugates Report Years Considered

Figure 7. Global Antibody-drug Conjugates Players Revenue Ranking (2023) & (US$ Million)

Figure 8. Global Antibody-drug Conjugates Players Sales Volume Ranking (2023) & (Kg)

Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Antibody-drug Conjugates Revenue in 2023

Figure 10. Antibody-drug Conjugates Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 11. Adcetris Picture

Figure 12. Kadcyla Picture

Figure 13. Global Antibody-drug Conjugates Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)

Figure 14. Global Antibody-drug Conjugates Sales Value Market Share by Type, 2023 & 2030

Figure 15. Global Antibody-drug Conjugates Sales Volume by Type (2019 VS 2023 VS 2030) & (Kg)

Figure 16. Global Antibody-drug Conjugates Sales Volume Market Share by Type, 2023 & 2030

Figure 17. Global Antibody-drug Conjugates Price by Type (2019-2030) & (USD/Kg)

Figure 18. Product Picture of Breast Cancer

Figure 19. Product Picture of Lymphoma

Figure 20. Global Antibody-drug Conjugates Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)

Figure 21. Global Antibody-drug Conjugates Sales Value Market Share by Application, 2023 & 2030

Figure 22. Global Antibody-drug Conjugates Sales Volume by Application (2019 VS 2023 VS 2030) & (Kg)

Figure 23. Global Antibody-drug Conjugates Sales Volume Market Share by Application, 2023 & 2030

Figure 24. Global Antibody-drug Conjugates Price by Application (2019-2030) & (USD/Kg)

Figure 25. North America Antibody-drug Conjugates Sales Value (2019-2030) & (US$ Million)

Figure 26. North America Antibody-drug Conjugates Sales Value by Country (%), 2023 VS 2030

Figure 27. Europe Antibody-drug Conjugates Sales Value (2019-2030) & (US$ Million)

Figure 28. Europe Antibody-drug Conjugates Sales Value by Country (%), 2023 VS 2030

Figure 29. Asia Pacific Antibody-drug Conjugates Sales Value (2019-2030) & (US$ Million)

Figure 30. Asia Pacific Antibody-drug Conjugates Sales Value by Country (%), 2023 VS 2030

Figure 31. South America Antibody-drug Conjugates Sales Value (2019-2030) & (US$ Million)

Figure 32. South America Antibody-drug Conjugates Sales Value by Country (%), 2023 VS 2030

Figure 33. Middle East & Africa Antibody-drug Conjugates Sales Value (2019-2030) & (US$ Million)

Figure 34. Middle East & Africa Antibody-drug Conjugates Sales Value by Country (%), 2023 VS 2030

Figure 35. Key Countries/Regions Antibody-drug Conjugates Sales Value (%), (2019-2030)

Figure 36. Key Countries/Regions Antibody-drug Conjugates Sales Volume (%), (2019-2030)

Figure 37. United States Antibody-drug Conjugates Sales Value, (2019-2030) & (US$ Million)

Figure 38. United States Antibody-drug Conjugates Sales Value by Type (%), 2023 VS 2030

Figure 39. United States Antibody-drug Conjugates Sales Value by Application (%), 2023 VS 2030

Figure 40. Europe Antibody-drug Conjugates Sales Value, (2019-2030) & (US$ Million)

Figure 41. Europe Antibody-drug Conjugates Sales Value by Type (%), 2023 VS 2030

Figure 42. Europe Antibody-drug Conjugates Sales Value by Application (%), 2023 VS 2030

Figure 43. China Antibody-drug Conjugates Sales Value, (2019-2030) & (US$ Million)

Figure 44. China Antibody-drug Conjugates Sales Value by Type (%), 2023 VS 2030

Figure 45. China Antibody-drug Conjugates Sales Value by Application (%), 2023 VS 2030

Figure 46. Japan Antibody-drug Conjugates Sales Value, (2019-2030) & (US$ Million)

Figure 47. Japan Antibody-drug Conjugates Sales Value by Type (%), 2023 VS 2030

Figure 48. Japan Antibody-drug Conjugates Sales Value by Application (%), 2023 VS 2030

Figure 49. South Korea Antibody-drug Conjugates Sales Value, (2019-2030) & (US$ Million)

Figure 50. South Korea Antibody-drug Conjugates Sales Value by Type (%), 2023 VS 2030

Figure 51. South Korea Antibody-drug Conjugates Sales Value by Application (%), 2023 VS 2030

Figure 52. Southeast Asia Antibody-drug Conjugates Sales Value, (2019-2030) & (US$ Million)

Figure 53. Southeast Asia Antibody-drug Conjugates Sales Value by Type (%), 2023 VS 2030

Figure 54. Southeast Asia Antibody-drug Conjugates Sales Value by Application (%), 2023 VS 2030

Figure 55. India Antibody-drug Conjugates Sales Value, (2019-2030) & (US$ Million)

Figure 56. India Antibody-drug Conjugates Sales Value by Type (%), 2023 VS 2030

Figure 57. India Antibody-drug Conjugates Sales Value by Application (%), 2023 VS 2030

Figure 58. Antibody-drug Conjugates Industrial Chain

Figure 59. Antibody-drug Conjugates Manufacturing Cost Structure

Figure 60. Channels of Distribution (Direct Sales, and Distribution)

Figure 61. Bottom-up and Top-down Approaches for This Report

Figure 62. Data Triangulation

Figure 63. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3950

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Microcarrier Bioreactor Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-4O8609

Wed Apr 17 00:00:00 UTC 2024

Add to Cart

Global Immunohistochemistry Reagent Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-25I8231

Wed Apr 17 00:00:00 UTC 2024

Add to Cart

Global RNA Analysis & Transcriptomic Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-2M4266

Wed Apr 17 00:00:00 UTC 2024

Add to Cart

Global PCR Tubes And PCR Plates Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-38E8328

Wed Apr 17 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions